|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Breast Cancer
|
NCI
|
5R13CA121807-02
|
|
CSHL Conference on PTEN Pathways
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$7,000
|
|
Breast Cancer
|
NCI
|
1R21CA120204-01A1
|
|
Mammary Tumor Stem Cells
|
PEASTON, ANNE
|
JACKSON LABORATORY
|
ME
|
$234,900
|
|
Breast Cancer
|
NINR
|
1R01NR010939-01A2
|
|
Altered Brain Function in Chemotherapy for Breast Cancer
|
CIMPRICH, BERNADINE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$369,428
|
|
Breast Cancer
|
NCI
|
5R01CA114039-04
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$255,871
|
|
Breast Cancer
|
NCI
|
5R01CA079892-09
|
|
BRCA1 function in G2-M checkpoint and mitosis
|
OUCHI, TORU
|
EVANSTON NORTHWESTERN HEALTHCARE
|
IL
|
$216,896
|
|
Breast Cancer
|
NCI
|
5K08CA106597-03
|
|
Chromatin structure and BRCA1 Checkpoint Function
|
GREENBERG, ROGER
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$135,677
|
|
Breast Cancer
|
NCI
|
5R13CA110775-04
|
|
Workshop on the Nuclear Radiology of Breast Cancer
|
LEVIN, CRAIG
|
STANFORD UNIVERSITY
|
CA
|
$5,000
|
|
Breast Cancer
|
NIBIB
|
5R13CA110775-04
|
|
Workshop on the Nuclear Radiology of Breast Cancer
|
LEVIN, CRAIG
|
STANFORD UNIVERSITY
|
CA
|
$3,000
|
|
Breast Cancer
|
NCI
|
4R37CA058976-16
|
|
Molecular Analysis of the alpha6beta4 Integrin
|
GIANCOTTI, FILIPPO
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$410,916
|
|
Breast Cancer
|
NCI
|
4R37CA054281-16
|
|
Multiethnic Cohort Study of Diet and Cancer
|
KOLONEL, LAURENCE
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$2,292,128
|
|
Breast Cancer
|
NCI
|
4R37CA017542-33
|
|
Genetics of RNA Tumor Viruses
|
MARTIN, G
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$508,803
|
|
Breast Cancer
|
NCI
|
5R01CA063640-12
|
|
Breast Cancer Biology of Translational De-repression
|
HAGEDORN, CURT
|
UNIVERSITY OF UTAH
|
UT
|
$237,241
|
|
Breast Cancer
|
NCI
|
4R37CA046595-22
|
|
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
|
BLENIS, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$683,560
|
|
Breast Cancer
|
NCI
|
5R01CA079736-08
|
|
Role of Maspin in Breast Cancer Progression
|
ZHANG, MING
|
NORTHWESTERN UNIVERSITY
|
IL
|
$293,242
|
|
Breast Cancer
|
NCI
|
5R01MH063172-05
|
|
Risk of Major Depression Among Breast Cancer Patients
|
COYNE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$97,100
|
|
Breast Cancer
|
NIMH
|
5R01MH063172-05
|
|
Risk of Major Depression Among Breast Cancer Patients
|
COYNE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$503,206
|
|
Breast Cancer
|
NCI
|
5U01CA122171-03
|
|
Genomewide association in early-onset breast cancer
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
IL
|
$1,170,110
|
|
Breast Cancer
|
NIEHS
|
5R01ES015252-02
|
|
Molecular Basis of BRCA2-mediated DNA Repair and Cancer Avoidance
|
SUNG, PATRICK
|
YALE UNIVERSITY
|
CT
|
$359,887
|
|
Breast Cancer
|
NIEHS
|
5R01ES014626-02
|
|
Regulation of Sulfotransferases by LXR and its Implication in Pathophysiology
|
XIE, WEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$308,157
|
|
Breast Cancer
|
NCI
|
5R01CA113797-03
|
|
Targeted Alpha-Particle Emitter Therapy of Metastases
|
SGOUROS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$278,677
|
|
Breast Cancer
|
NCI
|
5R01CA080066-10
|
|
Pak1 - PIN Pathway in Breast Cancer Progression
|
KUMAR, RAKESH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$257,716
|
|
Breast Cancer
|
NCI
|
5R01CA085492-08
|
|
TGF-Beta Suppression and Promotion of Mammary Carcinomas
|
MOSES, HAROLD
|
VANDERBILT UNIVERSITY
|
TN
|
$441,398
|
|
Breast Cancer
|
NCI
|
2R01CA098779-07
|
|
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
|
LISANTI, MICHAEL
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$336,271
|
|
Breast Cancer
|
NCI
|
5R01CA030645-27
|
|
Glycosylation Mutants of Mice and Animal Cells
|
STANLEY, PAMELA
|
YESHIVA UNIVERSITY
|
NY
|
$508,261
|
|
Breast Cancer
|
NIEHS
|
5F32ES014777-02
|
|
Role of estrogen receptor beta in cancer prevention by dietary indole-3-carbinol
|
BENNINGHOFF, ABBY
|
OREGON STATE UNIVERSITY
|
OR
|
$24,398
|
|
Breast Cancer
|
NCI
|
5R01CA026869-29
|
|
PROGESTERONE RECEPTORS AND BREAST CANCER
|
HORWITZ, KATHRYN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$398,776
|
|
Breast Cancer
|
NCI
|
5R13CA119860-03
|
|
Annual San Antonio Breast Cancer Symposium
|
COLTMAN, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$5,000
|
|
Breast Cancer
|
NCI
|
5F32CA125984-02
|
|
Modeling Breast Carcinoma In Situ: Implications for Prevention and Control
|
STOUT, NATASHA
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$50,428
|
|
Breast Cancer
|
NHLBI
|
5R01HL049094-15
|
|
Cyclooxygenase-2 Regulation and Function
|
HLA, TIMOTHY
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$338,724
|
|
Breast Cancer
|
NCI
|
5R01CA120960-02
|
|
Functional and Clinical Analysis of Rak in Breast Cancer Suppression
|
LIN, SHIAW-YIH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$263,340
|
|
Breast Cancer
|
NCI
|
5R01CA057692-16
|
|
HYPOXIC STRESS MECHANISMS IN RADIATION AND CHEMOTHERAPY
|
MURPHY, BRIAN
|
SRI INTERNATIONAL
|
CA
|
$336,649
|
|
Breast Cancer
|
NCI
|
1R43CA114876-01A2
|
|
Botanical-derived drug discovery for cancer therapy
|
NORRIS, ANDREW
|
BCN BIOSCIENCES, LLC
|
CA
|
$130,207
|
|
Breast Cancer
|
NCI
|
5R01CA116620-02
|
|
Mechanisms of ATF3-induced mammary tumorigenesis
|
MACLEOD, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$292,600
|
|
Breast Cancer
|
NCI
|
5R01CA112176-04
|
|
Progression and regression of mammary preneoplasia
|
FURTH, PRISCILLA
|
GEORGETOWN UNIVERSITY
|
DC
|
$271,505
|
|
Breast Cancer
|
NIGMS
|
5R37GM044154-19
|
|
ENZYMES IN ORGANIC SYNTHESIS
|
WONG, CHI-HUEY
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$438,548
|
|
Breast Cancer
|
NCI
|
5R01CA115465-02
|
|
Syk and associated proteins in breast cancer
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$253,034
|
|
Breast Cancer
|
NCI
|
5F31CA110210-04
|
|
In vitro evaluation of uranium estrogenicity
|
RAYMOND-WHISH, STEFANIE
|
NORTHERN ARIZONA UNIVERSITY
|
AZ
|
$27,993
|
|
Breast Cancer
|
NCI
|
5R01CA106468-04
|
|
Functional role of p130Cas/BCAR1 in breast cancer
|
KIRSCH, KATHRIN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$282,526
|
|
Breast Cancer
|
NIDDK
|
5R01DK065961-05
|
|
Estrogen Receptor, MTA3, and Transcriptional Repression
|
BOSS, JEREMY
|
EMORY UNIVERSITY
|
GA
|
$250,219
|
|
Breast Cancer
|
NCI
|
5R01CA072877-09
|
|
The role of SEPT9 in cell proliferation and oncogenesis
|
PETTY, ELIZABETH
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$296,021
|
|
Breast Cancer
|
NCI
|
5R01CA125554-02
|
|
Mechanisms of estrogen action on bone marrow-derived stem stromal cells
|
KUPERWASSER, CHARLOTTE
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$310,650
|
|
Breast Cancer
|
NCI
|
5R01CA084360-09
|
|
Tumor and Stromal Metalloproteinases in Breast Cancer
|
MATRISIAN, LYNN
|
VANDERBILT UNIVERSITY
|
TN
|
$408,553
|
|
Breast Cancer
|
NCI
|
5R01CA080250-17
|
|
CAVEOLINS, SIGNALING AND CELL TRANSFORMATION
|
LISANTI, MICHAEL
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$341,174
|
|
Breast Cancer
|
NCI
|
5R01CA078814-10
|
|
New Triterpenoids for Cancer Chemoprevention & Therapy
|
SPORN, MICHAEL
|
DARTMOUTH COLLEGE
|
NH
|
$341,132
|
|
Breast Cancer
|
NCI
|
5R01CA125665-02
|
|
The Role of Thoc1 in Normal Development and Cancer
|
GOODRICH, DAVID
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$357,658
|
|
Breast Cancer
|
NCI
|
5R01CA107547-02
|
|
Brk Signals to ERK5 in Breast Cancer
|
LANGE, CAROL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$249,357
|
|
Breast Cancer
|
NCI
|
5R01CA101988-05
|
|
Dual Compartmental Targeting of Cancer
|
GUSTAFSON, DANIEL
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$224,150
|
|
Breast Cancer
|
NCI
|
5R01CA111360-04
|
|
Cyclin D1 and mammary carcinoma
|
DIEHL, J
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$290,858
|
|
Breast Cancer
|
NCI
|
5R01CA102590-04
|
|
Biointeractions of antiestrogens with nitric oxide
|
THATCHER, GREGORY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$229,652
|
|
Breast Cancer
|
NCI
|
5R01CA102113-04
|
|
Effects of MUC1 expression on erbB activity in neoplasia
|
SCHROEDER, JOYCE
|
UNIVERSITY OF ARIZONA
|
AZ
|
$226,218
|
|
Breast Cancer
|
NCI
|
5R01CA112412-04
|
|
Isomeric HRT estrogen-DNA adducts: Structure and Repair
|
GEACINTOV, NICHOLAS
|
NEW YORK UNIVERSITY
|
NY
|
$268,609
|
|
Breast Cancer
|
NCI
|
5R01CA104236-04
|
|
Phytonutrient Suppression of Wnt Signaling in Cancer
|
YEE, AMY
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$332,231
|
|
Breast Cancer
|
NHGRI
|
5R01CA104236-04
|
|
Phytonutrient Suppression of Wnt Signaling in Cancer
|
YEE, AMY
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$7,168
|
|
Breast Cancer
|
NCI
|
5R01CA101911-04
|
|
Information-Theoretic Based CAD in Mammography
|
TOURASSI, GEORGIA
|
DUKE UNIVERSITY
|
NC
|
$230,712
|
|
Breast Cancer
|
NCI
|
5R01CA106439-05
|
|
STATs as a Novel Approach to Cancer Therapy
|
TURKSON, JAMES
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$235,295
|
|
Breast Cancer
|
NCI
|
5R01CA109136-03
|
|
Novel Mechanisms of Carcinoma Cell Migration
|
O'CONNOR, KATHLEEN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$260,253
|
|
Breast Cancer
|
NCI
|
5R37CA034992-26
|
|
CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS
|
LIPPARD, STEPHEN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$672,247
|
|
Breast Cancer
|
NCI
|
5R01CA106263-04
|
|
Angiogenesis in Breast Cancer
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$318,352
|
|
Breast Cancer
|
NCI
|
5U24CA075362-11
|
|
IBCSG STATISTICAL CENTER--A BREAST CANCER STUDY RESOURCE
|
GELBER, RICHARD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$462,685
|
|
Breast Cancer
|
NCI
|
5F31CA113286-04
|
|
Association between prolactin and mammographic density
|
LEIRAS, CLAUDIA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$23,436
|
|
Breast Cancer
|
NCI
|
5R21CA125227-02
|
|
Microvascular Perfusion Sonographic Imaging to Detect Early Stage Ovarian Cancer
|
FISHMAN, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$164,859
|
|
Breast Cancer
|
NCI
|
5R21CA116525-02
|
|
Design of targeted native tropism-ablated adenovirus
|
DMITRIEV, IGOR
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$145,500
|
|
Breast Cancer
|
NIDDK
|
5R37DK048807-14
|
|
Mechanism of Action of Estrogens and Antiestrogens
|
MCDONNELL, DONALD
|
DUKE UNIVERSITY
|
NC
|
$437,931
|
|
Breast Cancer
|
NCI
|
5R01CA117930-03
|
|
Growth-Regulatory Signaling Networks in Breast Cancer
|
WAGNER, KAY-UWE
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$253,359
|
|
Breast Cancer
|
NCI
|
5R01CA082599-09
|
|
BRCA1 Modulates Estrogen Receptor Response in Breast Cancer
|
ROSEN, ELIOT
|
GEORGETOWN UNIVERSITY
|
DC
|
$250,168
|
|
Breast Cancer
|
NCI
|
5R01CA112199-04
|
|
Targeting mTOR for Cancer Therapy
|
MERIC-BERNSTAM, FUNDA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$233,253
|
|
Breast Cancer
|
NCI
|
5R01CA096613-05
|
|
Prolactin as a Growth Factor in Breast Cancer
|
BEN-JONATHAN, NIRA
|
UNIVERSITY OF CINCINNATI
|
OH
|
$238,696
|
|
Breast Cancer
|
NCI
|
5R01CA031230-24
|
|
Photodynamic Therapy Affects on the Tumor Microenvironment
|
GOMER, CHARLES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$336,685
|
|
Breast Cancer
|
NCI
|
5R01CA046475-17
|
|
Benign Breast Disease and Risk of Breast Cancer
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$340,162
|
|
Breast Cancer
|
NCI
|
5R01CA062212-13
|
|
TGF-betas and Receptors and Human Breast Cells
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
TN
|
$327,478
|
|
Breast Cancer
|
NIDDK
|
5R01DK066110-05
|
|
The Role of A Transcription Cofactor in Tumorigenesis
|
XIAO, HUA
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$245,546
|
|
Breast Cancer
|
NCI
|
5R01CA107469-04
|
|
Role of EZH2 in Breast Cancer
|
KLEER, CELINA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$257,343
|
|
Breast Cancer
|
NIDDK
|
5R01DK037871-26
|
|
Regulation of Sequential Protein Kinase Pathways
|
JOHNSON, GARY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$321,930
|
|
Breast Cancer
|
NCI
|
5R21CA125181-02
|
|
alphaBeta-crystallin: A Novel Biomarker in Breast Cancer
|
CRYNS, VINCENT
|
NORTHWESTERN UNIVERSITY
|
IL
|
$151,000
|
|
Breast Cancer
|
NCI
|
5R01CA056586-17
|
|
Cathepsins in Malignant Progression
|
SLOANE, BONNIE
|
WAYNE STATE UNIVERSITY
|
MI
|
$337,713
|
|
Breast Cancer
|
NIEHS
|
5R01ES015768-02
|
|
Mammary cancer suceptibility following in utero exposure to bisphenol A
|
KERI, RUTH
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$227,115
|
|
Breast Cancer
|
NCI
|
5R21CA115434-02
|
|
Genetic Signatures of Preinvasive Breast Disease
|
ROSENBERG, CAROL
|
BOSTON MEDICAL CENTER
|
MA
|
$161,000
|
|
Breast Cancer
|
NCI
|
5R37CA046120-20
|
|
The Role of Tumor Cell Surface Lectin in Metastases
|
RAZ, AVRAHAM
|
WAYNE STATE UNIVERSITY
|
MI
|
$348,945
|
|
Breast Cancer
|
NICHD
|
5R01HD032007-13
|
|
Progesterone Receptor A and B Proteins in Reproduction
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$314,656
|
|
Breast Cancer
|
NEI
|
5R01EY015305-04
|
|
Early patterning of the optic primordia
|
LANE, MARY
|
RICE UNIVERSITY
|
TX
|
$275,835
|
|
Breast Cancer
|
NCI
|
5R01CA089209-09
|
|
Mechanisms of Breast Carcinoma Survival
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$293,995
|
|
Breast Cancer
|
NCI
|
5R01CA114246-03
|
|
Injectable Engineered Tissue for Cancer Reconstruction
|
RUBIN, J
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$253,868
|
|
Breast Cancer
|
NIGMS
|
1SC2CA138179-01
|
|
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
|
AKALA, EMMANUEL
|
HOWARD UNIVERSITY
|
DC
|
$148,000
|
|
Breast Cancer
|
NHLBI
|
5R01HL073396-07
|
|
Role of Src family kinases in endothelial cell biology
|
ELICEIRI, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$347,625
|
|
Breast Cancer
|
NIGMS
|
1SC1CA138658-01
|
|
Involvement of Leptin and Interleukin-1 Signaling in Mammary Cancer Progression
|
GONZALEZ, RUBEN
|
MOREHOUSE SCHOOL OF MEDICINE
|
GA
|
$280,000
|
|
Breast Cancer
|
NIBIB
|
5R01EB005822-04
|
|
Biomagnetic Nanoparticles for Drug Delivery and Imaging
|
LABHASETWAR, VINOD
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$258,152
|
|
Breast Cancer
|
NIBIB
|
2R01EB002138-06
|
|
Breast CT scanner for earlier cancer detection
|
BOONE, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$1,093,701
|
|
Breast Cancer
|
NCI
|
5R01CA064389-15
|
|
Functional Study of a Carcinoma Associated Mucin MUC1
|
GENDLER, SANDRA
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
AZ
|
$346,110
|
|
Breast Cancer
|
NCI
|
1R01CA120003-01A2
|
|
Integrated Biochip Sensores for Detection of Cancer
|
BASHIR, RASHID
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$512,381
|
|
Breast Cancer
|
NCRR
|
1R21RR024398-01
|
|
Translational State Assay for Human Samples
|
BITTERMAN, PETER
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$188,750
|
|
Breast Cancer
|
NCI
|
5R01CA123541-03
|
|
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression
|
CARRAWAY, KERMIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$235,778
|
|
Breast Cancer
|
NCI
|
5R01CA107012-04
|
|
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas
|
FRIEDL, ANDREAS
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$269,300
|
|
Breast Cancer
|
NCI
|
5K25CA106863-04
|
|
Pressure-enhanced near-infrared breast cancer imaging
|
JIANG, SHUDONG
|
DARTMOUTH COLLEGE
|
NH
|
$100,324
|
|
Breast Cancer
|
NCI
|
5R01CA071727-08
|
|
Tumor Necrosis Factor-alpha Signaling in Breast Cancer
|
BASU, ALAKANANDA
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
TX
|
$223,842
|
|
Breast Cancer
|
NCI
|
5R01CA111421-04
|
|
Apoptosis by FADD in normal and cancerous cells
|
THORBURN, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$288,389
|
|
Breast Cancer
|
NCI
|
5R01CA042919-20
|
|
METALLOPROTEINASE INHIBITORS IN TUMOR PROGRESSION
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$253,961
|
|
Breast Cancer
|
NIDDK
|
5R01DK044525-14
|
|
Functions of the Brk Tyrosine Kinase in the Gastrointestinal Tract
|
TYNER, ANGELA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$311,395
|
|
Breast Cancer
|
NCI
|
5R01CA113395-03
|
|
MICROENVIRONMENTS OF INVASION IN HUMAN BREAST TUMORS
|
CONDEELIS, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$286,106
|
|
Breast Cancer
|
NCI
|
5R01CA106815-05
|
|
Lung cancer molecular markers by sex: intergroup study
|
AMBROSONE, CHRISTINE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$559,505
|
|
Breast Cancer
|
NCI
|
5R01CA106308-05
|
|
Genetic Regulatory Network in Mammary Tumorigenesis
|
HSU, WEI
|
UNIVERSITY OF ROCHESTER
|
NY
|
$306,145
|
|
Breast Cancer
|
NCI
|
5R01CA104757-04
|
|
Enhancement of HER-2/neu-based therapy using HSP110
|
MANJILI, MASOUD
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$223,222
|
|
Breast Cancer
|
NCI
|
5R01CA120278-02
|
|
Cyclooxygenase Modulators of Immune Function in Breast Cancer
|
FULTON, AMY
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$278,333
|
|
Breast Cancer
|
NCI
|
5R01CA112553-03
|
|
An Anti-Proliferative Role of HER4 in Breast Cancer
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$251,635
|
|
Breast Cancer
|
NCI
|
5R01CA105023-03
|
|
Effects of Tibetan Yoga on Fatigue and Sleep in Cancer
|
COHEN, LORENZO
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$218,444
|
|
Breast Cancer
|
NCI
|
5R01CA113860-03
|
|
Role of coactivators in cell growth and tumorigenesis
|
CHEN, HONGWU
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$227,408
|
|
Breast Cancer
|
NCI
|
5R01CA044735-19
|
|
AROMATASE AND BREAST CANCER
|
CHEN, SHIUAN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$402,019
|
|
Breast Cancer
|
NCI
|
5R01CA114717-21
|
|
Placental 3B-Hydroxysteroid Dehydrogenase/Isomerase
|
THOMAS, JAMES
|
MERCER UNIVERSITY MACON
|
GA
|
$219,991
|
|
Breast Cancer
|
NIEHS
|
5R01ES013736-03
|
|
In Utero Organochlorine Exposure & Breast Density
|
COHN, BARBARA
|
PUBLIC HEALTH INSTITUTE
|
CA
|
$266,169
|
|
Breast Cancer
|
NIGMS
|
5R01GM077391-02
|
|
Ceramide, Membrane Glycolipids and Glycoprotein Expression
|
CABOT, MYLES
|
JOHN WAYNE CANCER INSTITUTE
|
CA
|
$445,797
|
|
Breast Cancer
|
NCI
|
5R01CA108585-03
|
|
Armed Replicating Ad for Breast Cancer Bone Metastasis
|
DOUGLAS, JOANNE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$225,695
|
|
Breast Cancer
|
NCI
|
1R01CA131029-01
|
|
Fatigue, depression, and inflammation in cancer survivors: A prospective study
|
KIECOLT-GLASER, JANICE
|
OHIO STATE UNIVERSITY
|
OH
|
$864,589
|
|
Breast Cancer
|
NCI
|
5R01CA060731-14
|
|
AFAP-110 regulates signals that affect F-actin
|
FLYNN, DANIEL
|
WEST VIRGINIA UNIVERSITY
|
WV
|
$254,627
|
|
Breast Cancer
|
NCI
|
5U10CA118735-03
|
|
NSABP Participating Sites
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$66,231
|
|
Breast Cancer
|
NCI
|
5U10CA044066-23
|
|
NSABP Participating site
|
ROBIDOUX, ANDRE
|
UNIVERSITY OF MONTREAL HOSPITAL
|
CANADA
|
$29,083
|
|
Breast Cancer
|
NCI
|
5U10CA020156-33
|
|
Primary Breast Cancer Therapy Group
|
MARGOLESE, RICHARD
|
SIR MORTIMER B. DAVIS JEWISH GEN HOSP
|
CANADA
|
$31,289
|
|
Breast Cancer
|
NCI
|
5R01CA125063-02
|
|
Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins
|
PETRENKO, VALERY
|
AUBURN UNIVERSITY AT AUBURN
|
AL
|
$373,539
|
|
Breast Cancer
|
NCI
|
5R01CA079756-08
|
|
P53-Mediated G1/M Checkpoint Controls Altered by PPM1D
|
MERCER, W
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$238,892
|
|
Breast Cancer
|
NCI
|
5R01CA109462-03
|
|
Role of an RNA-Binding Protein in Mammary Carcinogenesis
|
ROSS, JEFFREY
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$381,151
|
|
Breast Cancer
|
NCI
|
1R01CA131270-01
|
|
Macrophages and Tumor Angiogenesis
|
POLLARD, JEFFREY
|
YESHIVA UNIVERSITY
|
NY
|
$344,350
|
|
Breast Cancer
|
NIAAA
|
1R01AA017226-01
|
|
Alcohol and Breast Cancer
|
LUO, JIA
|
WEST VIRGINIA UNIVERSITY
|
WV
|
$329,625
|
|
Breast Cancer
|
NCI
|
5R01CA109294-03
|
|
MECHANISMS OF ESTROGEN RECEPTOR REGULATION
|
WEIGEL, RONALD
|
UNIVERSITY OF IOWA
|
IA
|
$231,383
|
|
Breast Cancer
|
NCI
|
5R01CA082497-12
|
|
Ultrasonic Elasticity Imaging of the Breast
|
INSANA, MICHAEL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$359,650
|
|
Breast Cancer
|
NIGMS
|
5F31GM078857-02
|
|
MARC Predoctoral Fellowship Program
|
BAERGA, REBECCA
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$29,206
|
|
Breast Cancer
|
NCI
|
1R43CA131257-01
|
|
Recovery of viable exfoliated cells using microfluidics for clinical diagnostics
|
KRUMMEL, KURT
|
CELULA, INC.
|
CA
|
$99,999
|
|
Breast Cancer
|
NCI
|
5R01CA097375-05
|
|
Luteal Adjuvant Oophorectomy in Vietnamese Breast Cancer
|
LOVE, RICHARD
|
OHIO STATE UNIVERSITY
|
OH
|
$533,075
|
|
Breast Cancer
|
NCI
|
5R01CA064462-12
|
|
GlcNAcT-V Regulation of Cell Surface Structure/Function
|
PIERCE, J
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$352,110
|
|
Breast Cancer
|
NCI
|
5R01CA050385-20
|
|
Risk Factors for Breast Cancer in Younger Nurses
|
WILLETT, WALTER
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$2,042,455
|
|
Breast Cancer
|
NCI
|
5R01CA118495-03
|
|
Structure/Function Analysis of Icmt
|
PHILIPS, MARK
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$291,276
|
|
Breast Cancer
|
NCI
|
5R01CA112021-04
|
|
A Novel Breast Cancer Biomarker
|
SGROI, DENNIS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$280,337
|
|
Breast Cancer
|
NCI
|
5R01CA109231-04
|
|
PET Imaging of Breast Cancer Using Oncogene Expression
|
THAKUR, MATHEW
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$404,031
|
|
Breast Cancer
|
NCI
|
5R01CA080843-07
|
|
Effects of Soy on Estrogens in Breast Fluid and Urine
|
MASKARINEC, GERTRAUD
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$330,868
|
|
Breast Cancer
|
NCI
|
5R01CA049449-19
|
|
Biochemical Markers in the nurses' Health Study Cohort
|
HANKINSON, SUSAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,213,763
|
|
Breast Cancer
|
NCI
|
5R01CA105436-05
|
|
p63 Signaling in Epithelial Cell Growth and Cancer
|
PIETENPOL, JENNIFER
|
VANDERBILT UNIVERSITY
|
TN
|
$293,511
|
|
Breast Cancer
|
NCI
|
5R01CA115197-04
|
|
EGFR Targeted Nanoparticles to Overcome Paclitaxel Resistant Breast Cancer
|
MUMPER, RUSSELL
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$235,901
|
|
Breast Cancer
|
NCI
|
5R01CA120009-03
|
|
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
|
DOU, QING
|
WAYNE STATE UNIVERSITY
|
MI
|
$233,544
|
|
Breast Cancer
|
NCI
|
5R01CA113559-03
|
|
The function of RhoBTB proteins
|
SOLTOFF, STEPHEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$293,000
|
|
Breast Cancer
|
NCI
|
5R01CA084325-09
|
|
Translational control of p27 in breast cancer cells
|
MISKIMINS, W
|
UNIVERSITY OF SOUTH DAKOTA
|
SD
|
$219,106
|
|
Breast Cancer
|
NINDS
|
5R01NS056218-03
|
|
Effects of Radiation on Brain Microvasculature and Cognition
|
SONNTAG, WILLIAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$351,506
|
|
Breast Cancer
|
NCI
|
5R01CA100844-05
|
|
Erythropoietin receptors in breast cancer
|
ARCASOY, MURAT
|
DUKE UNIVERSITY
|
NC
|
$269,406
|
|
Breast Cancer
|
NCI
|
5R01CA116813-03
|
|
Post-Transcriptional Regulation of MMTV
|
DUDLEY, JAQUELIN
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$256,806
|
|
Breast Cancer
|
NCI
|
5R01CA065622-15
|
|
Determinants of Tissue Estradiol Sensitivity
|
SANTEN, RICHARD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$268,655
|
|
Breast Cancer
|
NCI
|
5R37CA016303-33
|
|
Hormonal Regulation of Breast Cancer
|
ROSEN, JEFFREY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$763,328
|
|
Breast Cancer
|
NCI
|
5R01CA105452-04
|
|
Genetic modifiers of mammary tumor susceptibility
|
JERRY, D
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$286,406
|
|
Breast Cancer
|
NCI
|
5R01CA054273-16
|
|
Aberrant Retinoid Signaling in Breast Cancer
|
OSSOWSKI, LILIANA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$288,714
|
|
Breast Cancer
|
NCI
|
5R01CA114301-04
|
|
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell
|
CHEN, JIN
|
VANDERBILT UNIVERSITY
|
TN
|
$287,453
|
|
Breast Cancer
|
NCI
|
5R01CA039742-24
|
|
Epidemiology of Cancer in a Cohort of Older Women
|
FOLSOM, AARON
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$522,496
|
|
Breast Cancer
|
NCI
|
5R01CA064710-12
|
|
Facilitating Positive Adaptation to Breast Cancer
|
ANTONI, MICHAEL
|
UNIVERSITY OF MIAMI CORAL GABLES
|
FL
|
$449,588
|
|
Breast Cancer
|
NCI
|
5R01CA115751-03
|
|
Fra-1: A new target for a genomic breast cancer vaccine
|
REISFELD, RALPH
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$326,609
|
|
Breast Cancer
|
NCI
|
5R01CA127405-02
|
|
Klf4 in tumor initiation and maintenance of squamous cell carcinoma
|
RUPPERT, JOHN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$275,500
|
|
Breast Cancer
|
NCI
|
5R01CA109254-04
|
|
Drug-Induced Destabilization of Bcl-2 mRNA
|
FERNANDES, DANIEL
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$264,795
|
|
Breast Cancer
|
NCI
|
1K07CA131473-01
|
|
Skin Toxicity Effects in Breast Radiation: A Cognitive Behavioral Intervention
|
SCHNUR, JULIE
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$134,723
|
|
Breast Cancer
|
NCI
|
5R01CA097226-05
|
|
The Role of HOXA5 in Breast Cancer
|
RAMAN, VENU
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$286,025
|
|
Breast Cancer
|
NCRR
|
7K01RR021858-03
|
|
Interactions of PRL, Estrogen, and TFFa in Mammary Cancer
|
ARENDT, LISA
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$118,335
|
|
Breast Cancer
|
NCI
|
5R01CA109174-03
|
|
Developing Multi-Genic Anti-Breast Cancer Therapies
|
DEBS, ROBERT
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$283,865
|
|
Breast Cancer
|
NCI
|
5R01CA109274-03
|
|
Genetic effectors of TGF-beta induced growth and arrest.
|
PARK, BEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$254,392
|
|
Breast Cancer
|
NCI
|
5R01CA100373-05
|
|
Palpation Imaging
|
HALL, TIMOTHY
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$345,358
|
|
Breast Cancer
|
NCI
|
5R01CA112398-04
|
|
Ultrawideband Microwave Detection of Breast Cancer`
|
HAGNESS, SUSAN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$200,138
|
|
Breast Cancer
|
NCI
|
5R01CA113477-04
|
|
Role of AIB1 in Growth Factor Signaling
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
DC
|
$290,637
|
|
Breast Cancer
|
NCI
|
5R01CA060750-15
|
|
Mechanisms of tumor promotion and carcinogenesis
|
HONKANEN, RICHARD
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$249,183
|
|
Breast Cancer
|
NCI
|
1R01CA132012-01
|
|
Nanoimmunoliposome-Complexed SPIO: Tumor-Specific Detection of Early Lung Cancer
|
CHANG, ESTHER
|
GEORGETOWN UNIVERSITY
|
DC
|
$614,637
|
|
Breast Cancer
|
NCI
|
1R21CA132068-01
|
|
Spin Probes in Semipermeable Nanospheres: EPR spectroscopy & imaging of tumor pH
|
KHRAMTSOV, VALERY
|
OHIO STATE UNIVERSITY
|
OH
|
$168,750
|
|
Breast Cancer
|
NHGRI
|
5R01HG003880-03
|
|
Improved design and analysis of diploid resequencing microarrays
|
KULP, DAVID
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$296,144
|
|
Breast Cancer
|
NCI
|
5R01CA114340-02
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$253,417
|
|
Breast Cancer
|
NCI
|
5R01CA103920-05
|
|
BRCA1 and the Inactive X Chromosome
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$329,983
|
|
Breast Cancer
|
NCI
|
5U10CA013612-35
|
|
SOUTHWEST ONCOLOGY GROUP
|
MILLER, THOMAS
|
UNIVERSITY OF ARIZONA
|
AZ
|
$266,506
|
|
Breast Cancer
|
NCI
|
5R01CA070823-10
|
|
Iron, NO, and Lipid Peroxides in Photodynamic Therapy
|
GIROTTI, ALBERT
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$247,951
|
|
Breast Cancer
|
NCI
|
5R01CA109325-04
|
|
Functional Analysis of Histologic Grade in Breast Cancer
|
DAIRKEE, SHANAZ
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
CA
|
$261,573
|
|
Breast Cancer
|
NCI
|
5R01CA089481-08
|
|
Receptor mediated breast cancer therapy
|
GREENE, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$249,851
|
|
Breast Cancer
|
NCI
|
5R01CA058860-14
|
|
Hereditary Breast Cancer: Genetic and Molecular Studies
|
ANTON-CULVER, HODA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$613,625
|
|
Breast Cancer
|
NCI
|
5R01CA118294-02
|
|
System Optimization For Breast Sonography
|
INSANA, MICHAEL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$257,428
|
|
Breast Cancer
|
NCI
|
5U10CA069651-15
|
|
Biostatistical Center for the NSABP
|
COSTANTINO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$3,800,453
|
|
Breast Cancer
|
NCI
|
5R01CA104581-05
|
|
Molecular & Genetic Determinants of Outcome in Breast Cancer
|
DEMICHELE, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$296,181
|
|
Breast Cancer
|
NCI
|
1R15CA125493-01A1
|
|
Selective KGFR Antagonists for the Prevention of Cancer Metastasis
|
PENTO, J
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$219,750
|
|
Breast Cancer
|
NIGMS
|
5R01GM049882-13
|
|
FAK/Src/CAS Signaling in Cell Motility and Invasion
|
HANKS, STEVEN
|
VANDERBILT UNIVERSITY
|
TN
|
$319,093
|
|
Breast Cancer
|
NCI
|
5R01CA098832-04
|
|
Cadmium, Metallothionein and Breast Cancer Progression
|
SENS, MARY
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$269,231
|
|
Breast Cancer
|
NCI
|
5R01CA106424-04
|
|
Molecular Dissection of Growth Factor Receptor Signaling
|
PANDEY, AKHILESH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$276,404
|
|
Breast Cancer
|
NCI
|
1R21CA126635-01A1
|
|
Using New Optical Techniques to Study Cell Signaling in 3D Matrices
|
KEELY, PATRICIA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$147,000
|
|
Breast Cancer
|
NCI
|
1R01CA127645-01A1
|
|
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
|
SUH, NANJOO
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
NJ
|
$250,092
|
|
Breast Cancer
|
NCI
|
5R01CA078356-10
|
|
Novel p53 target gene ASC in apoptosis & mammary tumorigenesis
|
LEE, SAM
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$273,706
|
|
Breast Cancer
|
NCI
|
5R01CA107013-04
|
|
Retinoic acid, CRABP, and cancer
|
NOY, NOA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$363,658
|
|
Breast Cancer
|
NCI
|
2R01CA092440-06A1
|
|
A novel growth regulatory factor in breast cells
|
MONTANO, MONICA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$273,657
|
|
Breast Cancer
|
NCI
|
2R01CA074285-11A1
|
|
Targeting the IGF System in Breast Cancer
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$354,219
|
|
Breast Cancer
|
NIEHS
|
5R01ES008258-10
|
|
Endocrine Disrupting Chemicals and Aromatase
|
CHEN, SHIUAN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
CA
|
$298,371
|
|
Breast Cancer
|
NCI
|
5R01CA113952-04
|
|
Adhesion signaling by a novel mitotic substrate of src
|
MOASSER, MARK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$255,337
|
|
Breast Cancer
|
NCI
|
5R01CA119139-03
|
|
The Role of Prolactin in the Etiology of Postmenopausal Breast Cancer
|
TWOROGER, SHELLEY
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$193,715
|
|
Breast Cancer
|
NCI
|
5R01CA114210-04
|
|
IN-VIVO CONDUCTIVITY IMAGING OF TUMORS WITH MREIT
|
MUFTULER, L
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$279,053
|
|
Breast Cancer
|
NIEHS
|
5K01ES012645-05
|
|
Molecular Epidemiology of Xenoestrogen Exposure
|
TEITELBAUM, SUSAN
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$119,568
|
|
Breast Cancer
|
NCI
|
5R01CA101858-05
|
|
Intermittent food restriction prevents mammary tumors
|
CLEARY, MARGOT
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$233,253
|
|
Breast Cancer
|
NCI
|
1R21CA132039-01
|
|
Application of a Novel Nanotechnology for Molecular Profiling of Tumor Cellular E
|
NELSON, EDWARD
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$183,000
|
|
Breast Cancer
|
NCI
|
5R01CA079466-09
|
|
Statistical Methods for Breast Cancer Screening Studies
|
SHEN, YU
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$122,316
|
|
Breast Cancer
|
NCI
|
5R01CA113859-03
|
|
The Role of Regulation of FOXO3a in Tumor Suppression
|
HU, MICKEY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$234,227
|
|
Breast Cancer
|
NCI
|
5K05CA111696-04
|
|
Benign Breast Disease: A New Frontier for Prevention
|
DALY, MARY
|
FOX CHASE CANCER CENTER
|
PA
|
$115,759
|
|
Breast Cancer
|
NCI
|
1R43CA132081-01
|
|
Quantitative Proteomics of Metastasis
|
KRIZMAN, DAVID
|
EXPRESSION PATHOLOGY, INC
|
MD
|
$147,875
|
|
Breast Cancer
|
NCI
|
5R01CA116235-03
|
|
Epithelial-stromal cell interactions in breast cancer
|
POLYAK, KORNELIA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$294,724
|
|
Breast Cancer
|
NCI
|
5R01CA109330-03
|
|
Molecular Basis of Aneuploidy
|
PATI, DEBANANDA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$232,676
|
|
Breast Cancer
|
NIGMS
|
5K01GM080578-02
|
|
Laboratory Training and Research in Breast Cancer
|
GUNASEKARAN, MUTHUKUMARAN
|
FISK UNIVERSITY
|
TN
|
$49,759
|
|
Breast Cancer
|
NCI
|
1R01CA126968-01A1
|
|
CBT +/- Modafinil for Insomnia and Fatigue following Chemotherapy
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
NY
|
$474,827
|
|
Breast Cancer
|
NCI
|
1R01CA127617-01A1
|
|
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?
|
MANDELBLATT, JEANNE
|
GEORGETOWN UNIVERSITY
|
DC
|
$668,007
|
|
Breast Cancer
|
NCI
|
5R01CA111482-03
|
|
PDK1 and PPARdelta Signaling in Mammary Tumorigenesis
|
GLAZER, ROBERT
|
GEORGETOWN UNIVERSITY
|
DC
|
$286,495
|
|
Breast Cancer
|
NCI
|
1R01CA118015-01A1
|
|
Role of PP2A in Lung Cancer
|
WALTER, GERNOT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$320,588
|
|
Breast Cancer
|
NIDDK
|
1R01DK074652-01A2
|
|
Validation of the Estrogen Related Receptor as a therapeutic target in cancer
|
MCDONNELL, DONALD
|
DUKE UNIVERSITY
|
NC
|
$331,500
|
|
Breast Cancer
|
NIGMS
|
1R01GM069754-01A3
|
|
Enzymology of Dimethylargininase
|
FAST, WALTER
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$252,360
|
|
Breast Cancer
|
NIBIB
|
1R01EB007276-01A1
|
|
NEAR INFRARED PH-SENSITIVE MOLECULAR PROBES FOR MICROSCOPY OF CELLS AND TISSUES
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
MO
|
$296,568
|
|
Breast Cancer
|
NCI
|
2U01CA098710-05
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
GA
|
$1,063,219
|
|
Breast Cancer
|
NCI
|
2U01CA098216-05
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
RIBOLI, ELIO
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
UK
|
$1,299,337
|
|
Breast Cancer
|
NIGMS
|
5R01GM035269-23
|
|
Structural Studies of Nucleoprotein Complexes
|
EGELMAN, EDWARD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$303,948
|
|
Breast Cancer
|
NCI
|
5R01CA116494-02
|
|
The IGF Signaling Pathway and Breast Cancer Risk
|
NEUHAUSEN, SUSAN
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$525,564
|
|
Breast Cancer
|
NCI
|
5R01CA115883-02
|
|
TC-Labeled Cyclic RGDfK Tetramers for Breast Cancer Imaging
|
LIU, SHUANG
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$263,559
|
|
Breast Cancer
|
NCI
|
5R01CA095164-05
|
|
Hormonal regulation of p53 activity in mammary tissue
|
JERRY, D
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$271,155
|
|
Breast Cancer
|
NCI
|
1R01CA122756-01A2
|
|
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
|
CAI, QIUYIN
|
VANDERBILT UNIVERSITY
|
TN
|
$533,242
|
|
Breast Cancer
|
NCI
|
1R01CA123359-01A2
|
|
Non-apoptotic functions of caspases
|
FRISCH, STEVEN
|
WEST VIRGINIA UNIVERSITY
|
WV
|
$273,589
|
|
Breast Cancer
|
NCI
|
5R03CA128103-02
|
|
Development of Statistical Approaches Allowing for Genetic Covariates
|
WU, CHIH-CHIEH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$77,000
|
|
Breast Cancer
|
NCI
|
7K99CA127361-02
|
|
P190-B RhoGAP regulates the microenvironment in the developing mammary gland
|
GOGOLA, TRACY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$127,754
|
|
Breast Cancer
|
NCI
|
5R01CA127380-02
|
|
Oncolytic Adenovirus-sTGFbetaRIIFc Targeting Breast Cancer Bone Metastasis
|
SETH, PREM
|
EVANSTON NORTHWESTERN HEALTHCARE
|
IL
|
$278,805
|
|
Breast Cancer
|
NCI
|
1R01CA127239-01A1
|
|
pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics
|
NATARAJAN, AMARNATH
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$270,000
|
|
Breast Cancer
|
NCI
|
1R01CA127383-01A1
|
|
The Tumor Suppressive Role of CHD5
|
MILLS, ALEA
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$348,513
|
|
Breast Cancer
|
NCI
|
5R03CA123619-02
|
|
Mammographic density, genes and estradiol/norethisterone based EPT regimens
|
URSIN, GISKE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$81,500
|
|
Breast Cancer
|
NCI
|
5U10CA046282-21
|
|
Southwest Oncology Group
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$382,959
|
|
Breast Cancer
|
NCI
|
5R01CA123203-02
|
|
Discovering TREX1 and TREX2 Function in Mammalian Cells and Mice
|
HASTY, EDWARD
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$277,400
|
|
Breast Cancer
|
NCI
|
5R01CA116167-02
|
|
BRCA2 missense mutations and breast cancer
|
COUCH, FERGUS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$526,502
|
|
Breast Cancer
|
NCI
|
5R01CA113851-02
|
|
Local Radiation as an Adjuvant for Immunotherapy
|
DEMARIA, SANDRA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$322,050
|
|
Breast Cancer
|
NCI
|
5K99CA126980-02
|
|
Breast cancer stem cells and their cellular origin
|
LI, ZHE
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$136,820
|
|
Breast Cancer
|
NHGRI
|
5R03HG004055-02
|
|
Economic Evaluations of Emerging Genomic Tests for Early Stage Breast Cancer
|
SHIH, YA-CHEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$77,000
|
|
Breast Cancer
|
NIGMS
|
5F31GM079805-02
|
|
Immune modulation by MUC1 secreting tumor cells
|
ILKOVITCH, DAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$34,025
|
|
Breast Cancer
|
NHLBI
|
1R01HL084469-01A2
|
|
Adaptive glutathione responses to cigarette smoke in COPD
|
DAY, BRIAN
|
NATIONAL JEWISH HEALTH
|
CO
|
$389,160
|
|
Breast Cancer
|
NIDDK
|
2K24DK062895-06
|
|
Osteoporosis in Older Men and Women
|
GREENSPAN, SUSAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$179,335
|
|
Breast Cancer
|
NINR
|
1R21NR009868-01A2
|
|
Facilitating Web-based Patient Decision Support for Hereditary Breast Cancer Risk
|
ROPKA, MARY
|
FOX CHASE CANCER CENTER
|
PA
|
$259,000
|
|
Breast Cancer
|
NCI
|
1R01CA119202-01A2
|
|
Disparity in Quality of Breast Cancer Treatment and Effects on Outcomes
|
GRIGGS, JENNIFER
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$548,716
|
|
Breast Cancer
|
NICHD
|
1R21HD053762-01A2
|
|
ANALYSIS OF CHROMATIN REMODELING IN MAMMARY GLAND DEVELOPMENT USING TILING ARRAYS
|
RIJNKELS, MONIQUE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$207,399
|
|
Breast Cancer
|
NCI
|
5R01CA043318-23
|
|
Methylation of the Calcitonin Gene in Human Tumors
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$418,048
|
|
Breast Cancer
|
NHLBI
|
5R01HL081147-03
|
|
Regulation of Estrogen Signaling by Tuberin and Rheb
|
HENSKE, ELIZABETH
|
FOX CHASE CANCER CENTER
|
PA
|
$415,103
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
0012
|
Risk Stratification for Subsequent Tumors in Women with DCIS
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$189,868
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
0013
|
Genomic Approaches to Breast Cancer Subset Identification and Treatment
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$145,553
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
0014
|
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes
|
PARK, JOHN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$213,344
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
0015
|
Breast Cancer Therapeutic Agents Based on Telomerase Misfunction
|
BLACKBURN, ELIZABETH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$143,984
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9007
|
Tissue and Outcomes Core
|
LJUNG, BRITT-MARIE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$191,867
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9008
|
Biostatistics Core
|
MOORE, DAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$78,455
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9009
|
Bioinformatics Core
|
SPELLMAN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$88,923
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9006
|
Advocacy Core
|
PARK, JOHN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$71,458
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9010
|
Developmental Research Program
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$95,989
|
|
Breast Cancer
|
NCI
|
2P50CA058207-14
|
9011
|
Career Development Program
|
GRAY, JOE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$95,989
|
|
Breast Cancer
|
NCI
|
5R01CA116662-03
|
|
A novel intracellular 7TM estrogen receptor in breast
|
PROSSNITZ, ERIC
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$258,530
|
|
Breast Cancer
|
NCI
|
5R01CA018119-32
|
|
ANTIESTROGENS: MECHANISM OF ANTAGONIST ACTION
|
KATZENELLENBOGEN, BENITA
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$322,811
|
|
Breast Cancer
|
NCI
|
1K22CA120092-01A2
|
|
Functional Vitamin D Receptor Gene Variants and Racial/Ethnic Cancer Disparities
|
WILSON, ROBIN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$147,451
|
|
Breast Cancer
|
NCI
|
1P01CA124570-01A1
|
0002
|
Genetic Alterations That Initiate Follicular Thyroid Carcinogenesis
|
ENG, CHARIS
|
CLEVELAND CLINIC FOUNDATION
|
OH
|
$581,007
|
|
Breast Cancer
|
NCI
|
2P50CA058183-14
|
0014
|
Targeting the HER2 Pathway: Mechanisms of Resistance & Strategies to Overcome
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$161,961
|
|
Breast Cancer
|
NCI
|
2P50CA058183-14
|
0015
|
Treatment Resistance Pathways & Targeting Residula Cancers
|
CHANG, JENNY
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$155,217
|
|
Breast Cancer
|
NCI
|
2P50CA058183-14
|
0016
|
Combination Chemoprevention: Prevention of Both ER-Positive & ER-Negative BC
|
BROWN, POWEL
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$155,438
|
|
Breast Cancer
|
NCI
|
2P50CA058183-14
|
0017
|
Role of Androgen Receptor in Breast Cancer Progression
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$155,285
|
|
Breast Cancer
|
NCI
|
2P50CA058183-14
|
0018
|
Targeting the IGF Pathway for Treatment of Breast Cancer
|
LEE, ADRIAN
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$159,380
|
|
